Clinician India Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 19-12-2024
- Paid Up Capital ₹ 4.10 M
as on 19-12-2024
- Company Age 6 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 19.18%
(FY 2022)
- Profit 637.59%
(FY 2022)
- Ebitda 315.43%
(FY 2022)
- Net Worth 18.81%
(FY 2022)
- Total Assets 24.87%
(FY 2022)
About Clinician India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 4.10 M, as per Ministry of Corporate Affairs (MCA) records.
Subramanyam Ramesh, Merybal Barnabas, Malini Merybal, and One other member serve as directors at the Company.
- CIN/LLPIN
U85300TN2018PTC122345
- Company No.
122345
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Apr 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Clinician India?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Merary Balasingh  | Director | 25-Apr-2018 | Current |
| Subramanyam Ramesh | Additional Director | 30-Sep-2022 | Current |
| Merybal Barnabas | Additional Director | 30-Sep-2022 | Current |
| Malini Merybal | Director | 25-Apr-2018 | Current |
Financial Performance of Clinician India.
Clinician India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 19.18% increase. The company also saw a substantial improvement in profitability, with a 637.59% increase in profit. The company's net worth Soared by an impressive increase of 18.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Clinician India?
Unlock access to Clinician India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Pacific Technical Services India Private LimitedActive 32 years 9 daysSubramanyam Ramesh is a mutual person
Operational Energy Group India LimitedActive 30 years 5 monthsSubramanyam Ramesh is a mutual person
- Oeg Defence And Aerospace Private LimitedActive 10 months 20 days
Subramanyam Ramesh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Clinician India?
Unlock and access historical data on people associated with Clinician India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Clinician India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Clinician India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
